LZB-201

Autoimmune Disorders

PreclinicalActive

Key Facts

Indication

Autoimmune Disorders

Phase

Preclinical

Status

Active

Company

An Indian biotech developing next-generation antibody therapeutics for oncology and immunology using advanced engineering platforms.

Drug	Company	Phase	Status
TNB-512	Tenacia Biotechnology	Phase 1	Active
Biosimilar Candidate	MSN Laboratories	Pre‑clinical	Active
TYK2 Pseudokinase Inhibitor	A2A Pharma	Preclinical	Preclinical Development
Marine Membrane Lipid Extract(s)	Arctic Bioscience	Pre-clinical	Research & Development
Validated immunology target program	Genesis Therapeutics	Discovery	Active
NAMPT - Autoimmune	Remedy Plan Therapeutics	Discovery	Active
Autoimmunity Diagnostics	Eurobio	Commercial	Active